Stock Screener App

無料 -

インストール

3.61

4.18% 0.145

Titan Pharmaceuticals Inc De (TTNP)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測株式分割

Titan Pharmaceuticals Inc De (TTNP) 最新ニュース

KalVista Pharmaceuticals Taps Former AVEO Oncology Executive as New COO in Strategic Leadership Move - StockTitan

Hepion Pharmaceuticals Terminates Strategic Merger with Pharma Two BMajor Deal Cancelled - StockTitan

MIRA Pharmaceuticals' Novel Ketamine Drug Aces Preclinical Safety Tests, Phase I Trials Set for 2025 - StockTitan

Universe Pharmaceuticals Announces $15M Direct Offering with Warrants; Univest Securities Leading Placement - StockTitan

Fresh Tracks Therapeutics Faces Dissolution as Court Schedules Critical Delaware Hearing | FRTX Stock News - StockTitan

KalVista Pharmaceuticals Awards Inducement Stock Options to New Executive Team Members - StockTitan

Heron Therapeutics Wins Major Patent Battle Over CINVANTI, Blocks Generic Until 2035 - StockTitan

X4 Pharmaceuticals Issues Major Stock Option Awards to New Employees at $0.371 Per Share - StockTitan

VSee Health CEO Reveals AI Platform's 1.5M Monthly Telehealth Encounters on Bloomberg TV - StockTitan

Terns Pharmaceuticals Grants 150,000 Share Options to New Employee at $6.24 - StockTitan

Titan Pharmaceuticals faces Nasdaq compliance issues - Investing.com

Titan Pharmaceuticals Faces Double Nasdaq Compliance Challenge Over Filing, Audit Issues | TTNP Stock News - StockTitan

Citius Pharmaceuticals Announces 1-for-25 Reverse Stock Split to Maintain Nasdaq Listing | CTXR Stock News - StockTitan

Conduit Pharma Secures Key Patent for Autoimmune Drug AZD1656 in Major Japan Market | CDT Stock News - StockTitan

Lexicon Pharmaceuticals Appoints Former Eisai CEO Ivan Cheung to Board of Directors | LXRX Stock News - StockTitan

Melt Pharma's MELT-300 Shows Breakthrough Results in Phase 3 Sedation Trial | HROW Stock News - StockTitan

Napo Therapeutics Wins 'Best Pharma Innovator' Award, Advances Rare Disease Drug Trials | JAGX Stock News - StockTitan

Catalyst Pharmaceuticals CEO to Present at Major Healthcare Conferences | CPRX Stock News - StockTitan

NeuroBo Pharma Rebrands as MetaVia, Advances $70M Cardiometabolic Pipeline | NRBO Stock News - StockTitan

Virpax Pharmaceuticals Raises $5M to Advance Pain Management Drug Development | VRPX Stock News - StockTitan

CNS Pharmaceuticals Completes 252-Patient Enrollment in Pivotal Brain Cancer Study - StockTitan

Elite Pharmaceuticals Revenue Surges 33% to $18.9M, Operating Profit Jumps 84% | ELTP Stock News - StockTitan

TFF Pharmaceuticals Announces Complete Shutdown, Appoints Wind-Down Specialist as CEO | TFFP Stock News - StockTitan

Meiji Seika Pharma Invests in ARCALIS to Boost Japan's mRNA Vaccine Production - StockTitan

Virpax Pharmaceuticals Raises $5M in Public Offering to Advance Pain Management Drug | VRPX Stock News - StockTitan

Catalyst Pharmaceuticals Named Among BioSpace's Top 50 Best Places to Work 2025 | CPRX Stock News - StockTitan

Universe Pharmaceuticals Announces 15:1 Reverse Stock Split Amid NASDAQ Concerns | UPC Stock News - StockTitan

Acurx Pharma Q3: New Patent Win & Trial Progress Despite Cash Decline to $5.8M | ACXP Stock News - StockTitan

Syros Pharma Stock Alert: Phase 3 Trial Fails, Loan Default Triggered | SYRS Stock News - StockTitan

Longboard Pharma Launches Groundbreaking Phase 3 Trial for Rare Epilepsy Treatment | LBPH Stock News - StockTitan

Marinus (MRNS) Q3 Revenue Jumps 56%, Faces Setbacks in Clinical Trials - StockTitan

CERo's Cancer Drug Shows Breakthrough: Kills Ovarian Cancer Without Toxicity in Key Study | CERO Stock News - StockTitan

Hepion & Pharma Two B Merger Advances: SEC Approves Key Registration for $HEPA Deal | HEPA Stock News - StockTitan

InMed Announces 1-for-20 Reverse Split to Maintain Nasdaq Listing - StockTitan

NRx Pharmaceuticals Sets Q3 2024 Earnings Call for November 14 | NRXP Stock News - StockTitan

NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results - StockTitan

Ionis Pharmaceuticals to Present at 6 Major Healthcare Investor Conferences | IONS Stock News - StockTitan

Amylyx Reports Mixed Q3: Positive Trial Data Despite $72.7M Loss, Cash Runway Into 2026 | AMLX Stock News - StockTitan

Madrigal Pharmaceuticals to Present at Three Major Healthcare Investor Conferences | MDGL Stock News - StockTitan

Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024 - StockTitan

InMed Gets Nasdaq Lifeline: 20:1 Share Consolidation Plan to Avoid Delisting | INM Stock News - StockTitan

Bionoid Pharma Unveils 5-Year AI-Powered Growth Strategy, Targets 15% EBITDA | BINP Stock News - StockTitan

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - StockTitan

Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement - StockTitan

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - StockTitan

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline - StockTitan

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes - StockTitan

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split - StockTitan

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - StockTitan

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer - StockTitan

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics - StockTitan

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan

NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC - StockTitan

Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 - StockTitan

MIRA Pharmaceuticals' Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain - StockTitan

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call - StockTitan

Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives - StockTitan

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024 - StockTitan

INCY

$69.56

0.50%

SMMT

$19.28

1.47%

MRNA

$40.43

0.40%

UTHR

$364.10

0.90%

BGNE

$184.68

1.68%

BNTX

$113.77

0.32%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く